Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: ADAPTIVE BIOTECHNOLOGIES CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-07-03 to 2024-08-05
Current total value of award: $76200
Description: ADAPTIVE IMMUNOSEQUENCING SERVICE